euroPLX 48 Lisbon Schedules 4,000 Face-to-Face Meetings


Cascais/Lisbon, 6 March 2012. Business development delegates of 170 companies from 36 countries convened in Cascais, near Lisbon, Portugal for over 4,000 targeted business negotiations around pharma and life science product developments, licensing, marketing or similar issues.

An average of almost 24 pre-scheduled one-to-one appointments per attending company on 5 and 6 March 2012 supports the reputation of euroPLX Meetings as being more productive than most other partnering conferences.

"Partnering event productivity is measured by business negotiations per company, not by the total number of scheduled face-to-face meetings. The total number does not say anything about the benefit for the customer. Large events brag about 10,000 scheduled appointments, but for each of the 2,000 or so participating companies this is a meager 5 appointments!" says Dr. Norbert Rau, one of the initiators and organisers of euroPLX. "And from customer feedback we know that 10 to 12 appointments result in one contract, i.e. a participating company can expect about two deals per euroPLX Meeting, on condition that the company's business opportunity offered is reasonably attractive. That is what we call productivity."

With 48 partnering events held since 1995, euroPLX Meetings are not only the most frequently held pharma and life science partnering events worldwide. euroPLX also prides itself on its internationality and on customers who keep returning more often than to any other partnering event of this industry sector.

The next euroPLX Meeting, euroPLX 49 Istanbul, will be held on 4 and 5 June, 2012, and is open for registration on